550. Neurocognitive Decline in People Living with HIV in India and Correlation with 3T Magnetic Resonance Spectroscopy
Session: Poster Abstract Session: HIV and Central Nervous System
Thursday, October 5, 2017
Room: Poster Hall CD

Background: 

Neurocognitive decline in asymptomatic HIV patients and its correlation with metabolic changes in brain has not been studied in developing countries like India. In the present study we aim to examine the correlation between cognitive decline and changes in brain metabolites using MRS.

Methods: 

ART naïve HIV­positive patients, in the age group 20­50 years attending ART center of the hospital from
July to December 2016 were included in the study. All patients underwent evaluation using MRS of left frontal white matter (FWM) and left basal ganglia (BG). Levels of N­acetyl aspartate (tNAA), choline (tCho), creatine (tCr), lipids and macromolecules at 0.9ppm (Lip09+MM09) were measured. Cognition was tested using a battery validated for Indian population. Locally normalized z­scores were used to calculate brain dysfunction score. Spearman correlation coefficient was used to assess the correlation between two continuous variables. There were 28 (29% female and 71% male) cases and 30 (37% female and 63% male) controls

Results: 

The mean age was comparable in the 2 groups (33 and 34 years). There was a significant difference (p< 0.05) in the concentration (mmol/kg) of tNAA (9.29±311 vs 7.45±0.64), tCho (2.08±0.70 vs 1.74±0.25), tCr (6.95±2.56 vs 5.43±0.61), in the FWM and Lip09 + MM09 (5.87±1.05 vs 4.80±0.35) in BG, with higher levels in controls. There was no significant correlation between CD4 count and metabolites or overall dysfunction score and metabolites except Cr in FWM with more dysfunction associated with lower concentration [see Table 1 for summary]

Graph 1: MR spectrum acquired from FWM of a patient.

Conclusion: 

The results show that HIV­-associated changes are present in asymptomatic people which may be
contributing to the early neurocognitive decline. Knowledge of metabolic changes within studied brain regions can help understand the pathology and design interventions to cater to this unmet need in people living with HIV.

 

Kartik Gupta, M.B.B.S1, Virendra Kumar, Ph.D2 and Sanjeev Sinha, M.D1, (1)Medicine, All India Institute of Medical Sciences, New Delhi, India, (2)NMR, All India Institute of Medical Sciences, New Delhi, India

Disclosures:

K. Gupta, None

V. Kumar, None

S. Sinha, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.